The evolving field of biodefence: Therapeutic developments and diagnostics

被引：118

作者：

Burnett, JC

Henchal, EA

Schmaljohn, AL

Bavari, S ^{[1
]}

机构：

[1] NCI, Dev Therapeut Program, Based Drug Discovery Grp, SAIC, Frederick, MD 21702 USA

[2] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2005年 / 4卷 / 04期

关键词：

D O I：

10.1038/nrd1694

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.

引用

收藏

页码：281 / 297

页数：17

相关论文

共 206 条

[61] Differentiation of filoviruses by electron microscopy [J].

Geisbert, TW ;

Jahrling, PB .

VIRUS RESEARCH, 1995, 39 (2-3) :129-150

[62] Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event [J].

Geisbert, TW ;

Young, HA ;

Jahrling, PB ;

Davis, KJ ;

Kagan, E ;

Hensley, LE .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) :1618-1629

[63] Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys [J].

Geisbert, TW ;

Hensley, LE ;

Jahrling, PB ;

Larsen, T ;

Geisbert, JB ;

Paragas, J ;

Young, HA ;

Fredeking, TM ;

Rote, WE ;

Vlasuk, GP .

LANCET, 2003, 362 (9400) :1953-1958

[64] A national laboratory network for bioterrorism: Evolution from a prototype network of laboratories performing routine surveillance [J].

Gilchrist, JR .

MILITARY MEDICINE, 2000, 165 (07) :28-31

[65]

GILCHRIST MJR, 2000, LAB SAFETY MANAGEMEN

[66] Taking the measure of countermeasures: Leaders' views on the nation's capacity to develop biodefense countermeasures [J].

Gilfillan, L ;

Smith, BT ;

Inglesby, TV ;

Kodukula, K ;

Schuler, A ;

Lister, M ;

O'Toole, T .

BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2004, 2 (04) :320-327

[67]

Goodchild J, 2004, CURR OPIN MOL THER, V6, P119

[68] The interferon antiviral response: from viral invasion to evasion [J].

Grandvaux, N ;

tenOever, BR ;

Servant, MJ ;

Hiscott, J .

CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (03) :259-267

[69] Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents [J].

Greenfield, RA ;

Bronze, MS .

DRUG DISCOVERY TODAY, 2003, 8 (19) :881-888

[70] Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure [J].

Hail, AS ;

Rossi, CA ;

Ludwig, GV ;

Ivins, BE ;

Tammariello, RF ;

Henchal, EA .

MILITARY MEDICINE, 1999, 164 (12) :833-837

← 2 3 4 5 6 7 8 9 10 11 →